ABBOTT INDIA Fact Sheet, ABBOTT INDIA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA Fact Sheet   (KNOL)


One Smallcap Stock: Showing All Signs of a Potential Crorepati Stock


Here is the latest financial fact sheet of ABBOTT INDIA. For more details, see the ABBOTT INDIA quarterly results and ABBOTT INDIA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ABBOTT INDIA Price History

Price Rs 17,991.2
Mkt Cap Rs m 382,300
Vol '000 0.5
P/E X 47.9
P/CF X 51.1
EPS (TTM) Rs 375.9
1 Day % -0.5
No. of shares m 21.25
1 Week % 0.5
1 Month % -1.1
1 Year % 9.8
52 week H/L Rs 23,902.3/15,525.0
As on Jun 27, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ABBOTT INDIA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ABBOTT INDIA EQUITY SHARE DATA
High Rs5,1906,1108,83416,86918,569 
Low Rs4,3513,9965,4587,15013,970 
Sales per share (Unadj.) Rs1,348.91,548.21,731.11,926.22,028.2 
Earnings per share (Unadj.) Rs130.2188.8211.9279.0325.0 
Diluted earnings per shareRs130.2188.8211.9279.0325.0 
Cash flow per share (Unadj.) Rs137.9196.4219.9307.1352.4 
Dividends per share (Unadj.) Rs40.0055.0065.00250.00275.00 
Adj. dividends per shareRs40.0055.0065.00250.01275.01 
Avg Dividend yield %0.81.10.92.11.7 
Book value per share (Unadj.) Rs646.4786.7932.21,127.51,203.7 
Adj. book value per shareRs646.4786.8932.21,127.51,203.8 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x3.53.34.16.28.0 
Avg P/E ratio x36.626.833.743.050.1 
P/CF ratio (eoy) x34.625.732.539.146.2 
Price / Book Value ratio x7.46.47.710.713.5 
Dividend payout %30.729.130.789.684.6 
Avg Mkt Cap Rs m101,370107,372151,843255,193345,717 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,4533,9374,3564,7614,927 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ABBOTT INDIA INCOME DATA
Net Sales Rs m28,66432,89936,78640,93143,100 
Other income Rs m6021,1811,1401,147835 
Total revenues Rs m29,26634,08037,92642,07843,935 
Gross profit Rs m3,9485,2346,0407,5629,189 
Depreciation Rs m164162169596581 
Interest Rs m20382285183 
Profit before tax Rs m4,3656,2156,9898,0279,260 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,5982,2032,4852,0982,353 
Profit after tax Rs m2,7664,0124,5035,9296,907 
Gross profit margin %13.815.916.418.521.3 
Effective tax rate %36.635.435.626.125.4 
Net profit margin %9.712.212.214.516.0 
ABBOTT INDIA BALANCE SHEET DATA
Current assets Rs m18,93022,65527,61032,04735,185 
Current liabilities Rs m6,3166,6818,5698,91110,309 
Net working cap to sales %44.048.651.856.557.7 
Current ratio x3.03.43.23.63.4 
Inventory Days Days66654 
Debtors Days Days22429227432 
Net fixed assets Rs m1,6041,3611,6693,2783,041 
Share capital Rs m212212212213213 
"Free" reserves Rs m13,52416,50619,59623,74725,366 
Net worth Rs m13,73616,71819,80823,95925,579 
Long term debt Rs m00000 
Total assets Rs m20,53424,01629,27835,32438,226 
Interest coverage x215.3163.6311.995.151.7 
Debt to equity ratio x00000 
Sales to assets ratio x1.41.41.31.21.1 
Return on assets %13.616.915.517.018.5 
Return on equity %20.124.022.724.727.0 
Return on capital %31.937.435.433.936.9 
Exports to sales %0.50.70.50.30.7 
Imports to sales %13.111.013.112.712.3 
Exports (fob) Rs m155239180118295 
Imports (cif) Rs m3,7413,6344,8195,1955,306 
Fx inflow Rs m228369369332353 
Fx outflow Rs m3,8293,8074,9185,2815,389 
Net fx Rs m-3,601-3,438-4,549-4,949-5,035 
ABBOTT INDIA CASH FLOW
From Operations Rs m 3,072 1,527 4,991 6,261 7,267 
From Investments Rs m -1,554 -2,148 -2,570 -4,012 -718 
From Financial Activity Rs m -898 -1,024 -1,428 -2,168 -5,818 
Net Cashflow Rs m 620 -1,646 993 81 731 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 75.0%
Institution 7.7%
Non-Institution 17.3%
Total 100.0%
Free Float 25.0%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Unit No. 3, Corporate Park, Sion Trombay Road, Mumbai - 400071
E-mail webmasterindia@abbott.com/investorrelations.india@abbott.com Web www.abbott.co.in
Tel 022-50461000/2000/1119/1117/1116/6797 8888 Fax 022-5016 9400
Sector PHARMACEUTICALS Group Abbott India - MNC
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 1.5

Read: ABBOTT INDIA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare ABBOTT INDIA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    


Yellow Ad

Advertisement

Our FREE Guide: Small Caps That Will Race Ahead of the Sensex

Richa Agarwal, our head of smallcap research, recently released the updated version of her very popular guide:

'Small Caps That Will Race Ahead of the Sensex':

When you sign-up for Richa's One Stock Crorepati mega summit, you get this premium guide worth Rs 950 for absolutely FREE.:

Learn more



Today's Market

Why Auto Stocks are Rising, the Latest on Cryptos, and Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets rose for the third consecutive session, as prospects of a slowing economic growth fanned hopes that global central banks may go slow on interest rate hikes.

Views on news

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling (Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS